It is a pharma private limited company based in Amaravati, Maharashtra, India, established in 1999.
1999 | Amaravati, Maharashtra, India | ActiveGlacier Pharmaceuticals Private Limited, a active private limited company, was established on 04 November 1999 in Amaravati, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24230MH1999PTC122545. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.90 M.
It upholds a compliant status. Its leadership includes Varsha Ashok Nanwani (Director), Ashok Inderjit Nanwani (Director). Past directors included Pramodkumar Gangabisanji Gattani, Jagdish Harikisan Navandar, Rajendrakumar Shivdayal Zanwar. It holds ₹1.90 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No G-5 M I D Cindustrial Area, Amaravati, Maharashtra, 444605.
U24230MH1999PTC122545
122545
04 November 1999
₹1.00 M
₹0.90 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Glacier Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Varsha Ashok Nanwani | Director | 06 Jan 2017 | Current |
| Ashok Inderjit Nanwani | Director | 01 Jan 2003 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Whole-Time Director | 20 Sep 2007 | Past |
| Pramod Abcsdd | Director | 06 Jan 2017 | Past |
| Pramod Abcsdd | Director | 20 Sep 2007 | Past |
| Pramod Abcsdd | Director | 06 Jan 2017 | Past |
| Pramod Abcsdd | Managing Director | 06 Jan 2017 | Past |
| Pramod Abcsdd | Director | 06 Jan 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Glacier Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 9.08% decrease. The company also saw a substantial fall in profitability, with a 13.91% decrease in profit. The company's net worth Soared by an impressive increase of 1059.78%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Glacier Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹19,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Dec 2017 | Others | ₹1.50 Cr | Open |
| 13 Mar 2007 | The Akola Urban Co-Op. Bank Ltd. | ₹4.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Glacier Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Glacier Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glacier Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Glacier Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
Progress on Glacier Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
Progress on A charge with Others amounted to Rs. 15.00 M with Charge ID 100187815 was registered on 05 Dec 2017. was documented.
Varsha Ashok Nanwani was appointed as a Director was appointed as a Director on 06 Jan 2017 & has been associated with this company since 8 years 11 months . was recorded as a recent event.
The activity A charge with The Akola Urban Co-Op. Bank Ltd. amounted to Rs. 4.00 M with Charge ID 10043458 was registered on 13 Mar 2007. was completed.
The activity Ashok Inderjit Nanwani was appointed as a Director was appointed as a Director on 01 Jan 2003 & has been associated with this company since 22 years 11 months . was completed.
The CIN of Glacier Pharmaceuticals Private Limited is U24230MH1999PTC122545.
Glacier Pharmaceuticals Private Limited is headquartered at Plot No G-5 M I D Cindustrial Area, Amaravati, Maharashtra, 444605.
Glacier Pharmaceuticals Private Limited was incorporated on 04 November 1999.
The current directors of Glacier Pharmaceuticals Private Limited are
The primary industry of Glacier Pharmaceuticals Private Limited is Trade.
Glacier Pharmaceuticals Private Limited is unlisted.
The authorized capital of Glacier Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.90 M.
The compliance status of Glacier Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX